On this episode, we sit down with the CEO & CTO of Circio to get into the world of circular RNA.


Erik, Thomas and the team are developing circVec, a circular RNA expression platform designed to make C&G therapies more powerful and durable.


The guys dig into the science & history behind circular RNA before discussing some initial data they have in heart, brain and other tissues, whilst explaining why this matters.


We also touch on the platform vs internal pipeline debate, their recent fundraising, partnering discussions and what to expect from Circio in the next 18 months.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Max Brennan - Biotech HeadHunter. Innehållet i podden är skapat av Max Brennan - Biotech HeadHunter och inte av, eller tillsammans med, Poddtoppen.